Share
Share
Arbor Research Collaborative for Health (Arbor Research) is pleased to announce its successful award of a position in a new subgroup within the General Services Administration (GSA) Schedule Contract focusing on Program Evaluation Services. The establishment of this subgroup will streamline the federal procurement process.
Program evaluation is a crucial aspect of federal initiatives, providing valuable insights to inform decision-making and enhance program effectiveness. Arbor Research is uniquely qualified with technical expertise and extensive experience in developing and implementing rigorous evaluation designs, including quasi-experimental, impact evaluations, and outcome evaluations.
“Arbor Research will bring its wealth of experience to address questions related to program implementation, the effectiveness of strategies, and factors influencing program variability” said Jeffrey Pearson, Health Policy and Practice Program Director. “Being part of this GSA Schedule Program Evaluation Subgroup underscores our commitment to advancing evidence-based practices and enhancing the impact of government initiatives.”
Arbor Research is equipped to design and implement various evaluation types and is committed to collecting and analyzing both qualitative and quantitative evaluation data, offering technical assistance and expertise, and developing and disseminating deliverables to diverse audiences.
“We are excited about the opportunity to contribute to the improvement of federal programs through our expertise in program evaluation,” said Eric Lammers, Senior Research Scientist. “This award positions Arbor Research to lend our skills to a variety of research opportunities that may become available through this vehicle.”
Arbor Research has an extensive history of collaborations with federal government agencies delivering high-quality program data to drive positive outcomes. For more information about Arbor Research Collaborative for Health and its capabilities, please visit: ArborResearch.org.
January 8, 2025 — Christopher Spera, President and CEO of Arbor Research Collaborative for Health, announced the election of Bryan K. Johnson, JD, MBA to the Arbor Research board of directors in 2025. Mr. Johnson was a co-founder of Insight Policy Research in 2001. His strategic development, operational management, and financial oversight led the start-up
December 5, 2024 — Arbor Research Collaborative for Health is proud to announce an innovative collaboration with the Nephrology Associates of Northern Illinois and Indiana (NANI), the largest private nephrology practice in the United States. This partnership marks a significant milestone in advancing chronic kidney disease (CKD) research and management by leveraging NANI’s extensive patient-level
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen